AcouSort AB (publ) (ACOU.ST)
SEK 3.74
(-0.8%)
SEK 3.74
(-0.8%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 25.87 Million SEK | 49.92% |
| 2022 | 17.26 Million SEK | 35.88% |
| 2021 | 12.7 Million SEK | 17.08% |
| 2020 | 10.84 Million SEK | 1.16% |
| 2019 | 10.72 Million SEK | 18.01% |
| 2018 | 9.08 Million SEK | 13.29% |
| 2017 | 8.02 Million SEK | 138.4% |
| 2016 | 3.36 Million SEK | 79.92% |
| 2015 | 1.87 Million SEK | 3.26% |
| 2014 | 1.81 Million SEK | 77.86% |
| 2013 | 1.01 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5.63 Million SEK | -0.32% |
| 2024 Q1 | 5.65 Million SEK | -22.05% |
| 2023 Q2 | 5.5 Million SEK | 13.92% |
| 2023 Q4 | 7.25 Million SEK | 49.47% |
| 2023 FY | 25.87 Million SEK | 49.92% |
| 2023 Q3 | 4.85 Million SEK | -11.87% |
| 2023 Q1 | 4.83 Million SEK | -10.41% |
| 2022 FY | 17.26 Million SEK | 35.88% |
| 2022 Q4 | 5.39 Million SEK | 33.28% |
| 2022 Q3 | 4.05 Million SEK | -1.05% |
| 2022 Q2 | 4.09 Million SEK | 10.09% |
| 2022 Q1 | 3.71 Million SEK | -50.12% |
| 2021 Q4 | 7.45 Million SEK | 142.49% |
| 2021 Q1 | 2.97 Million SEK | -19.71% |
| 2021 Q2 | 2.89 Million SEK | -2.82% |
| 2021 Q3 | 3.07 Million SEK | 6.37% |
| 2021 FY | 12.7 Million SEK | 17.08% |
| 2020 Q3 | 2.12 Million SEK | 0.09% |
| 2020 FY | 10.84 Million SEK | 1.16% |
| 2020 Q1 | 2.88 Million SEK | -15.18% |
| 2020 Q2 | 2.12 Million SEK | -26.35% |
| 2020 Q4 | 3.7 Million SEK | 73.98% |
| 2019 Q2 | 2.94 Million SEK | 26.47% |
| 2019 FY | 10.72 Million SEK | 18.01% |
| 2019 Q4 | 3.4 Million SEK | 66.1% |
| 2019 Q3 | 2.05 Million SEK | -30.34% |
| 2019 Q1 | 2.32 Million SEK | 11.07% |
| 2018 Q1 | 2.26 Million SEK | -1.99% |
| 2018 Q4 | 2.09 Million SEK | 0.48% |
| 2018 FY | 9.08 Million SEK | 13.29% |
| 2018 Q3 | 2.08 Million SEK | -18.3% |
| 2018 Q2 | 2.55 Million SEK | 12.72% |
| 2017 Q3 | 1.95 Million SEK | -21.19% |
| 2017 FY | 8.02 Million SEK | 138.4% |
| 2017 Q1 | 1.27 Million SEK | -46.65% |
| 2017 Q2 | 2.48 Million SEK | 94.82% |
| 2017 Q4 | 2.31 Million SEK | 18.1% |
| 2016 Q3 | 328 Thousand SEK | -49.23% |
| 2016 FY | 3.36 Million SEK | 79.92% |
| 2016 Q1 | 528 Thousand SEK | -51.35% |
| 2016 Q4 | 2.38 Million SEK | 628.05% |
| 2016 Q2 | 646 Thousand SEK | 22.35% |
| 2015 Q4 | 1.08 Million SEK | 434.63% |
| 2015 Q3 | 203 Thousand SEK | 0.0% |
| 2015 FY | 1.87 Million SEK | 3.26% |
| 2014 FY | 1.81 Million SEK | 77.86% |
| 2013 FY | 1.01 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Active Biotech AB (publ) | 44.8 Million SEK | 42.253% |
| Amniotics AB (publ) | 29.07 Million SEK | 10.993% |
| BioArctic AB (publ) | 89.62 Million SEK | 71.129% |
| Calliditas Therapeutics AB (publ) | 1.51 Billion SEK | 98.291% |
| Camurus AB (publ) | 1.05 Billion SEK | 97.558% |
| Cantargia AB (publ) | 290.01 Million SEK | 91.078% |
| Scandinavian ChemoTech AB (publ) | 21.89 Million SEK | -18.182% |
| CombiGene AB (publ) | 44.14 Million SEK | 41.383% |
| Diamyd Medical AB (publ) | 142.98 Million SEK | 81.903% |
| Genovis AB (publ.) | 88.19 Million SEK | 70.661% |
| Guard Therapeutics International AB (publ) | 115.07 Million SEK | 77.513% |
| Mendus AB (publ) | 129.13 Million SEK | 79.962% |
| Isofol Medical AB (publ) | 7.26 Million SEK | -256.026% |
| Intervacc AB (publ) | 79.78 Million SEK | 67.568% |
| Kancera AB (publ) | 63.07 Million SEK | 58.977% |
| Karolinska Development AB (publ) | 5.51 Million SEK | -368.853% |
| LIDDS AB (publ) | 27.75 Million SEK | 6.76% |
| Lipum AB (publ) | 37.3 Million SEK | 30.64% |
| Lipigon Pharmaceuticals AB (publ) | 7.25 Million SEK | -256.714% |
| Magle Chemoswed Holding AB (publ) | 135.91 Million SEK | 80.961% |
| NextCell Pharma AB | -576.01 Thousand SEK | 4592.213% |
| OncoZenge AB (publ) | 15.9 Million SEK | -62.691% |
| Saniona AB (publ) | 1.07 Million SEK | -2302.6% |
| Simris Alg AB (publ) | 38.64 Million SEK | 33.037% |
| Vicore Pharma Holding AB (publ) | 321.5 Million SEK | 91.952% |
| Xbrane Biopharma AB (publ) | 357.62 Million SEK | 92.764% |
| Xintela AB (publ) | 57.31 Million SEK | 54.854% |
| Xspray Pharma AB (publ) | 181.73 Million SEK | 85.762% |
| Ziccum AB (publ) | 27.87 Million SEK | 7.181% |
| Asarina Pharma AB (publ) | 14.65 Million SEK | -76.592% |
| Elicera Therapeutics AB (publ) | 28.32 Million SEK | 8.65% |
| Modus Therapeutics Holding AB (publ) | 16.4 Million SEK | -57.771% |
| Alligator Bioscience AB (publ) | 307.09 Million SEK | 91.574% |
| Sprint Bioscience AB (publ) | 42.63 Million SEK | 39.304% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | 17.68 Million SEK | -46.333% |
| Corline Biomedical AB | 30.16 Million SEK | 14.227% |
| IRLAB Therapeutics AB (publ) | 58.03 Million SEK | 55.41% |
| Bio-Works Technologies AB (publ) | 83.16 Million SEK | 68.887% |
| Aptahem AB (publ) | 10.01 Million SEK | -158.425% |
| Infant Bacterial Therapeutics AB (publ) | 134.69 Million SEK | 80.789% |
| Fluicell AB (publ) | 28.61 Million SEK | 9.578% |
| Biovica International AB (publ) | 133.72 Million SEK | 80.649% |
| Spago Nanomedical AB (publ) | 19.79 Million SEK | -30.753% |
| Abliva AB (publ) | 27.86 Million SEK | 7.141% |
| Egetis Therapeutics AB (publ) | 193.5 Million SEK | 86.627% |
| 2cureX AB (publ) | 36.51 Million SEK | 29.142% |
| I-Tech AB | 40.14 Million SEK | 35.548% |
| Hansa Biopharma AB (publ) | 859.44 Million SEK | 96.989% |
| Cyxone AB (publ) | 28.21 Million SEK | 8.287% |
| ExpreS2ion Biotech Holding AB (publ) | 109.36 Million SEK | 76.34% |
| Biosergen AB | 26.8 Million SEK | 3.48% |
| Nanologica AB (publ) | 69.88 Million SEK | 62.975% |
| SynAct Pharma AB | 224.49 Million SEK | 88.474% |
| Annexin Pharmaceuticals AB (publ) | 44.17 Million SEK | 41.425% |
| BioInvent International AB (publ) | 441.4 Million SEK | 94.138% |
| Stayble Therapeutics AB (publ) | 23.95 Million SEK | -8.023% |
| Alzinova AB (publ) | 36.39 Million SEK | 28.904% |
| Oncopeptides AB (publ) | 289.74 Million SEK | 91.069% |
| Pila Pharma AB (publ) | 7.85 Million SEK | -229.368% |
| Ascelia Pharma AB (publ) | 110.91 Million SEK | 76.67% |
| Diagonal Bio AB (publ) | 14.7 Million SEK | -76.027% |